TOM MURPHY

May 6, 2025 at 9:35 am

What customers can expect as Rite Aid closes or sells all its drugstores

Rite Aid customers can expect their local store to close or change ownership in the next few months as the struggling drugstore chain goes through...

• Business

May 5, 2025 at 1:49 pm

Rite Aid returns to bankruptcy protection as it seeks to sell most assets

Rite Aid is again seeking bankruptcy protection as the drugstore chain looks to sell all of its assets. It said stores will remain open for...

• Business

May 1, 2025 at 10:03 am

Lilly’s star weight-loss drug Zepbound faces coverage challenge from CVS Health

CVS Health will drop the weight-loss drug Zepbound from its insured pharmacy options this summer. Employers and insurers may follow suit.

• Business

May 1, 2025 at 5:55 am

CVS Health rides improving Medicare business to better-than-expected first quarter

CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better-than-expected first quarter.

• Business

April 30, 2025 at 6:57 am

What’s that rash? Put some thought into asking Google for medical help

Doctors say that internet searches for medical information should be done cautiously. Here are questions to keep in mind if you seek medical help online.

• Business

April 20, 2025 at 5:02 am

More pharmacies offer to speed prescription deliveries to customers

America’s two largest retailers want to deliver prescriptions to your doorstep, sometimes in a matter of hours.

• Business

April 17, 2025 at 4:15 am

UnitedHealth cuts 2025 forecast after dealing with first-quarter care use spike

A surprising Medicare Advantage cost spike helped push UnitedHealth into a rare deep dive Thursday, after the health care giant chopped its 2025 forecast following...

• Business

April 16, 2025 at 6:14 am

European regulators OK Alzheimer’s treatment Leqembi after initial doubts

European regulators have finally approved the Alzheimer’s treatment Leqembi after an advisory committee initially rejected the drug last summer.

• Business

April 14, 2025 at 5:42 am

Pfizer ends development of potential pill obesity treatment

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing.

• Business

April 8, 2025 at 7:58 am

Walgreens tops fiscal 2Q forecasts as private equity buyout awaits

Walgreens delivered a better-than-expected fiscal second quarter and a smaller loss a month after announcing that it would be bought by a private equity firm.

• Business